Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-825,000
Closed -$31.2M 112
2019
Q1
$31.2M Buy
825,000
+325,000
+65% +$12.1M 1.27% 21
2018
Q4
$18.2M Hold
500,000
0.67% 30
2018
Q3
$17.2M Hold
500,000
0.45% 34
2018
Q2
$16.1M Buy
500,000
+375,000
+300% +$13M 0.34% 29
2018
Q1
$3.6M Buy
+125,000
New +$3.3M 0.05% 82

Other funds holding IFRX

Artal Group's IFRX Position: Q2 2019 in Review

Artal Group sold out of InflaRx (IFRX) in Q2 2019, closing a stake of 825,000 shares — an estimated $31.2M sold.

Artal Group first reported a position in IFRX in Q1 2018 and held it in 5 quarters. The position peaked at $31.2M in Q1 2019. 28 funds tracked by Wall St. Rank hold IFRX as of Q2 2019.

  • Artal Group reported no remaining InflaRx position as of Q2 2019 after selling out during the quarter.
  • Artal Group sold 825,000 InflaRx shares in Q2 2019, an estimated $31.2M.
  • Artal Group first reported a position in InflaRx in Q1 2018 and held it in 5 quarters.
  • Artal Group's InflaRx position peaked at $31.2M in Q1 2019.
  • 28 funds tracked by Wall St. Rank held InflaRx as of Q2 2019.

Based on Artal Group's 13F filing for Q2 2019, filed 9 Aug 2019.